|
HERC4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.430400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.912200E-01 |
| Normal-vs-Stage2 |
2.512800E-01 |
| Normal-vs-Stage3 |
6.985400E-01 |
| Normal-vs-Stage4 |
9.399800E-01 |
| Stage1-vs-Stage2 |
1.649050E-01 |
| Stage1-vs-Stage3 |
7.706400E-01 |
| Stage1-vs-Stage4 |
9.861000E-01 |
| Stage2-vs-Stage3 |
1.849810E-01 |
| Stage2-vs-Stage4 |
4.078800E-01 |
| Stage3-vs-Stage4 |
8.714200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.599800E-01 |
| Normal-vs-AfricanAmerican |
5.283400E-01 |
| Normal-vs-Asian |
9.049900E-02 |
| Caucasian-vs-AfricanAmerican |
4.269800E-01 |
| Caucasian-vs-Asian |
8.828500E-02 |
| AfricanAmerican-vs-Asian |
6.443400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.826000E-01 |
| Normal-vs-Female |
2.463600E-02 |
| Male-vs-Female |
5.619900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.536200E-01 |
| Normal-vs-Extreme_Weight |
2.433200E-01 |
| Normal-vs-Obese |
6.334600E-01 |
| Normal-vs-Extreme_Obese |
8.606600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.234200E-01 |
| Normal_Weight-vs-Obese |
3.538800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.782200E-01 |
| Extreme_Weight-vs-Obese |
1.288350E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.049600E-01 |
| Obese-vs-Extreme_Obese |
6.956200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.616100E-02 |
| Normal-vs-Age(41-60Yrs) |
3.051400E-01 |
| Normal-vs-Age(61-80Yrs) |
8.112000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.349500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.107810E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.099100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.939800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.797420E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.192470E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.035600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.918600E-01 |
| Normal-VS-Type2 PRCC |
5.556400E-02 |
| Normal-VS-KIRP CIMP |
2.075200E-03 |
| Normal-VS-Unclassified PRCC |
5.352000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.317000E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.062300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.960000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.776520E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.546000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.054210E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.704000E-01 |
| Normal-vs-N1 |
2.518800E-01 |
| Normal-vs-N2 |
2.100600E-01 |
| N0-vs-N1 |
1.652800E-01 |
| N0-vs-N2 |
5.601800E-01 |
| N1-vs-N2 |
1.900750E-01 |
|
|
